Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

NCT03367572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1363

Enrollment

OTHER

Sponsor class

Conditions

Breast Carcinoma

Interventions

DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
DRUG: Netupitant/Palonosetron Hydrochloride
DRUG: Olanzapine
OTHER: Placebo
DRUG: Prochlorperazine
OTHER: Quality-of-Life Assessment

Sponsor

University of Rochester NCORP Research Base

Collaborators

[object Object]